In contrast, we found that double heterozygous p.R1628P(;)G2385R variant carriers exhibited a significantly earlier mean age of diagnosis (54.4 ± 9.1 years), which supports the hypothesis that interactions between multiple LRRK2 risk variants modulate PD pathogenesis66. This evidence concerns the gene LRRK2 and Parkinson disease.